AbstractIntroduction: Lymphatic filariasis (LF) is a mosquito-borne, chronically disabling tropical disease caused by infection with thread-like parasitic filarial worms Wuchereriabancrofti, Brugiamalayi, and B. timori. It is an ancient disease and was recorded in India as early as 6th century BC by the famous Indian surgeon Susruta in his book Susruta Samhita. Aims and Objectives: To Study Coverage, Compliance and awareness of Lymphatic Filariasis and mass drug administration in Osmanabad District Methodology: MDA activity was carried out by health staff of DMO (District Malaria Office) on 14th to 20th December 2015 for 3 days in rural area and for 5 days in urban area. The evaluation was done by Community Medicine, Dept. of GMC Latur, during February 2016 The statistical analysis done by Z-test (Difference between Two Proportions) The overall coverage was 100% and the compliance i.e. No of Eligible who consumed Drug was Overall 94.29% and in Rural Area was Pethsangavi, Turori, Jekekur was 95.83% ( i.e. 437 out of 456) and in Urban area Bharat Nagar (ward )Umarga was 90.28% i.e. 158 out of 175. This observed difference between Compliance of Urban and Rural is statistically significant. (Z= 2.689, P<0.001). The major reason for Not –Swallowing the drugs were Beneficiaries empty Stomach(47.82%), followed by Not aware of Lymphatic Filariasis (23.18%), H/O Complications of Previous year MDA(10.14%) and beneficieries thinks that No need as no symptoms to them (7.24%), Fear of Drugs (5.79%). Beneficiaries choices Drug Distributor were Health worker (Male)-(80.16%), ANM ( -12.39%) AWW-(3.30%), NGO-(0.82%), Volunteer (3.30%) Conclusion: In the present study the coverage and Compliance was found much improved than previous studies but the reasons of not swallowing like are still prevailed in the area like empty Stomach Not aware of Lymphatic Filariasis, history Complications, Fear of Drugs etc. should be worked on these issues to improve future Compliance to drugs.

Keyword: Coverage, Compliance and Awareness Mass Drug Administration, MDA (Mass Drug Administration), Lymphatic Filariasis.